PMID- 7690969 OWN - NLM STAT- MEDLINE DCOM- 19931020 LR - 20190501 IS - 0027-8424 (Print) IS - 1091-6490 (Electronic) IS - 0027-8424 (Linking) VI - 90 IP - 18 DP - 1993 Sep 15 TI - Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults. PG - 8707-11 AB - Using optimal culture conditions in which the transforming growth factor beta 1 (TGF-beta 1) inhibitory loop has been interrupted by antisense TGF-beta 1 oligonucleotides or anti-TGF-beta serum, we have compared the proliferative capacities and the abilities of the CD34+ CD38- cell populations from bone marrow and umbilical cord blood to generate early progenitors in long-term cultures. The CD34+ CD38- fraction of umbilical cord blood accounts for 4% of the CD34+ fraction compared to only 1% in bone marrow, indicating that umbilical cord blood may be relatively enriched in stem cells. We estimate that the CD34+ CD38- cells from a typical umbilical cord blood sample produce equivalent numbers of colony-forming units (CFU)-granulocyte/erythrocyte/macrophage/megakaryocyte, twice as many CFU-granulocyte/macrophage (GM) and 3 times as many burst-forming units-erythroid as the same population from an average bone marrow sample used in adult transplantation. In addition, the colonies resulting from the umbilical cord blood samples were significantly larger than those from bone marrow, indicating a greater growth potential. However, the content of later progenitors, which may be important for short-term reconstitution, was less in umbilical cord blood-derived than in bone marrow-derived cell preparations, as estimated by a 4-fold lower production of CFU-GM in long-term cultures of CD34+ CD38+ cells. This deficit is partially compensated by the higher growth capacity of the resulting CFU-GM. These studies suggest that umbilical cord blood is a suitable source of cells for adult transplantation. FAU - Cardoso, A A AU - Cardoso AA AD - Centre National de la Recherche Scientifique UPR 272, Villejuif, France. FAU - Li, M L AU - Li ML FAU - Batard, P AU - Batard P FAU - Hatzfeld, A AU - Hatzfeld A FAU - Brown, E L AU - Brown EL FAU - Levesque, J P AU - Levesque JP FAU - Sookdeo, H AU - Sookdeo H FAU - Panterne, B AU - Panterne B FAU - Sansilvestri, P AU - Sansilvestri P FAU - Clark, S C AU - Clark SC AU - et al. LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Antigens, CD) RN - 0 (Antigens, CD34) RN - 0 (Antigens, Differentiation) RN - 0 (Growth Substances) RN - 0 (Membrane Glycoproteins) RN - 0 (Oligodeoxyribonucleotides) RN - 0 (Oligonucleotides, Antisense) RN - 0 (Recombinant Proteins) RN - 0 (Transforming Growth Factor beta) RN - EC 3.2.2.5 (ADP-ribosyl Cyclase) RN - EC 3.2.2.5 (CD38 protein, human) RN - EC 3.2.2.6 (ADP-ribosyl Cyclase 1) SB - IM MH - ADP-ribosyl Cyclase MH - ADP-ribosyl Cyclase 1 MH - Adult MH - Antigens, CD/*blood MH - Antigens, CD34 MH - Antigens, Differentiation/*blood MH - *Bone Marrow Cells MH - Cell Division/drug effects MH - Cells, Cultured MH - Colony-Forming Units Assay MH - Fetal Blood/*cytology/immunology MH - Growth Substances/*pharmacology MH - Hematopoietic Stem Cells/*cytology/drug effects/immunology MH - Humans MH - Kinetics MH - Membrane Glycoproteins MH - Oligodeoxyribonucleotides/pharmacology MH - Oligonucleotides, Antisense/pharmacology MH - Recombinant Proteins/pharmacology MH - Transforming Growth Factor beta/genetics/physiology PMC - PMC47427 EDAT- 1993/09/15 00:00 MHDA- 1993/09/15 00:01 PMCR- 1994/03/15 CRDT- 1993/09/15 00:00 PHST- 1993/09/15 00:00 [pubmed] PHST- 1993/09/15 00:01 [medline] PHST- 1993/09/15 00:00 [entrez] PHST- 1994/03/15 00:00 [pmc-release] AID - 10.1073/pnas.90.18.8707 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8707-11. doi: 10.1073/pnas.90.18.8707.